glp 1 fgf21 agonist boehringer A novel GLP-1 and dual has therapeutic potential for diabetes and non-alcoholic steatohepatitis Transforming obesity: The advancement of

CYP3A4 Inducers The concomitant use of acetaminophen and codeine phosphate tablets and CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin) can result in lower codeine levels, greater norcodeine levels, and less metabolism via 2D6 with resultant lower morphine levels [see CLINICAL PHARMACOLOGY], resulting in decreased efficacy or onset of a withdrawal syndrome in patients who have developed physical dependence [see WARNINGS]

STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch

Stem Cell Rev Rep 2025;21:182234

Blood samples were collected every 3-6 months from birth for the assessment of type 1 diabetes related autoantibodies